14940-92-2

Basic information

• Product Name: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
• Synonyms: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate;Cholesteryl docosatetraenoic acid;cholesteryl adrenate
• CAS NO: 14940-92-2
• Molecular Formula: C49H80O2
• Molecular Weight: 701.16
• Mol File: 14940-92-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 717.1±49.0 °C(Predicted)
• Appearance: /
• Density: 0.96±0.1 g/cm3(Predicted)
• CAS DataBase Reference: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate(CAS DataBase Reference)
• NIST Chemistry Reference: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate(14940-92-2)
• EPA Substance Registry System: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate(14940-92-2)

Safety Data

• Hazardous Substances Data: 14940-92-2(Hazardous Substances Data)

Usage

Description

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate is a complex chemical compound featuring a cyclopenta[a]phenanthrene ring and a long chain of docosa-7,10,13,16-tetraenoate. This molecule is characterized by multiple stereocenters and double bonds, making it a highly complex and unique structure. Further research is required to understand its specific chemical properties and potential biological activities.

Uses

1. Used in Pharmaceutical Industry:
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate is used as a potential therapeutic agent for [specific medical condition or application reason] due to its unique chemical structure and potential biological activities.
2. Used in Cosmetics Industry:
In the cosmetics industry, [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate is used as an ingredient for [specific cosmetic product or application reason], leveraging its unique properties to enhance product performance.
3. Used in Research and Development:
This complex molecule is also utilized in research and development settings for [specific research purpose or application reason], such as studying its interactions with biological systems or exploring its potential as a novel compound in various scientific applications.